Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Aman Khera, EMBA, FRAPS, FTOPRA

Vice President, Regulatory Science, Strategy & Innovation
Worldwide Clinical Trials, Canada

Aman Khera is an innovative drug and device development leader with over twenty six years' experience in Regulatory Affairs in the Pharma/Biotech industry.

She is an advisor, board member and mentor in industry. For years, she pushed back against the perceived role regulatory teams should play and continues to lobby to make it a strategic role within companies and the industry. Her track record for anticipating, considering and addressing the inevitable regulatory challenges has changed the way people think about regulatory processes and the way the regulatory lens is viewed.
A divergent thinker, she is an expert in providing a broad range of high level strategic regulatory services and consultancy to companies worldwide. Holds extensive experience in regulatory strategy, support and intelligence for all aspects of developing and maintaining products in the pharma/biotech industry, worked with Regulatory Authorities all over the world as well as companies and people across the globe. By pushing the boundaries of where the regulator’s seat is, she has become a change agent throughout the industry.

A strong advocate for the importance of innovation, talent acquisition and talent retention. Passionate about the "people" aspect of the life sciences industry as well as strategic operations in building, engaging and retaining teams. In her view, justice, equity, diversity and inclusion go beyond issues of fairness; they are necessary parts of sound business and scientific practices, she is a committed champion for the industry.

With a deep foundation in regulatory affairs and the life sciences industry, Aman has taken a deep interest in how technological innovations will continue to disrupt the industry, but also how regulations, ethics and compliance will continue to have a loud voice at healthcare table while innovative transformations are occurring. She continues to scan the horizon of regulatory and life sciences transformations across the globe.

Disclosure information not submitted.

Presentation(s):